Institutional investors purchased a net $58.2 million shares of ABBV during the quarter ended September 2015, and now own 73.93% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 8.3 Million shares of AbbVie
WOODFORD INVESTMENT MANAGEMENT L... Bought 5.3 Million shares of AbbVie
BLACKROCK FINANCIAL MANAGEMENT, ... Bought 3.4 Million shares of AbbVie